SA 16/11/2026 – Money leaving the market – High selling pressure

Overall market trend: Bearish phase – day 46

Fridays market: Money leaving the market – High selling pressure

TC2000 McClellan: 6

Stocks above 40PMA T2108: 47

VIX: 19

52 week highs (US common stocks): 279

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX No trend

$QQQ: No trend

$SPY: No trend

$RSP: Uptrend

$DIA: No trend

$IWM: Downtrend

$BTC: Downtrend

$SQQQ: No trend

$UVIX: Downtrend

$TLT: Downtrend

$USO: Downtrend

$TNX: Uptrend

$GLD: Downtrend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors Friday:

  • None

2%- sectors Friday:

  • $SMH -2.99%
  • $XLK -2.01%

Main sectors monthly trailing:

  • Leading – $XLV $XHB
  • Lagging – $XLE $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $JETS
  • Lagging – $IGV $SMH

Bitcoin: 64k ish

Current market themes:

Theme 1: Big Pharma & GLP-1 Defensive Leadership

Catalyst: Investors are moving money out of AI and into steady earners. Lilly’s Q3 sales hit $24.4 billion, about $1.9 billion above forecasts, and AbbVie, Lilly and Gilead are trading at or near record highs.

Sectors: Big pharma, obesity drugs (GLP-1), large-cap biotech, medtech.

Conviction: High. Strong earnings plus a defensive bid while a rate hike is coming.

TickerCompanySector/IndustryLast (13 Nov)1D %Market CapYTDKey CatalystAnalyst Consensus
LLYEli Lilly and CompanyPharma / GLP-11443.501.26~$1.3T (verify)verifyRaised 2026 guidance; record highsverify
ABBVAbbVie Inc.Pharma295.030.20verify>25%52-week highs after Q3verify
JNJJohnson & JohnsonPharma / Medtech285.750.79verifyverifyDefensive rotationverify
MRKMerck & Co., Inc.Pharma147.760.55verifyverifyQ3 beatverify
AMGNAmgen Inc.Biotech / Obesity465.67-0.30verifyverifyObesity pipelineverify
GILDGilead Sciences, Inc.Biotech168.080.08verifyverifyNear record highsverify
AZNAstraZeneca PLC (ADR)Pharma184.450.04verifyverifyDefensive bidverify
NVONovo Nordisk A/S (ADR)Pharma / GLP-141.632.41verifyverifyGLP-1 laggard catch-upverify
BMYBristol-Myers Squibb CompanyPharma63.431.78verifyverifyValue rotationverify
PFEPfizer Inc.Pharma28.890.21verifyverifyLow-valuation defensiveverify
REGNRegeneron Pharmaceuticals, Inc.Biotech955.470.45verifyverifyPipeline momentumverify
VRTXVertex Pharmaceuticals IncorporatedBiotech538.60-0.74verifyverifyDefensive growthverify
ISRGIntuitive Surgical, Inc.Medtech / Robotics443.590.84verifyverifyProcedure growthverify
BSXBoston Scientific CorporationMedtech44.340.32verifyverifyMedtech rotationverify
VKTXViking Therapeutics, Inc.Biotech / Obesity29.225.95verifyverifyOral VK2735 heading to phase III in Q4 2026verify
ETFsXLV (188.85), IHE, IBB, XBI

Theme 2: Energy & the Hormuz Risk Premium

Catalyst: Energy is 2026’s best-performing sector, and it was one of the groups investors moved into on Friday. The risk is the oil price: Brent traded above $112 at the start of November, and the slide came on growing hopes for a US-Iran peace deal. Brent is now near $96 and WTI near $88.

Sectors: Integrated oil majors, oil producers, oilfield services, refiners, LNG.

Conviction: Medium. It’s an inflation hedge and still a geopolitical hedge, but it depends on what oil does next.

TickerCompanySector/IndustryLast (13 Nov)1D %Market CapYTDKey CatalystAnalyst Consensus
XOMExxon Mobil CorporationIntegrated Oil170.590.48verifyverifyHormuz headlines; Q3 beatverify
CVXChevron CorporationIntegrated Oil219.891.64verifyverifyOil price sensitivityverify
COPConocoPhillipsOil Producer142.281.59verifyverifyCrude reboundverify
EOGEOG Resources, Inc.Oil Producer158.321.74verifyverifyWent into 2026 completely unhedgedverify
OXYOccidental Petroleum CorporationOil Producer58.750.60verifyverifyAdjusted EPS of $1.91verify
DVNDevon Energy CorporationOil Producer46.580.76verifyverifyCrude betaverify
FANGDiamondback Energy, Inc.Oil Producer184.931.50verifyverifyPermian producerverify
SLBSLB N.V.Oilfield Services51.631.41verifyverifyInternational spendingverify
HALHalliburton CompanyOilfield Services33.502.26verifyverifyOilfield services recoveryverify
BKRBaker Hughes CompanyOilfield Services / LNG Equipment49.441.19verifyverifyLNG and power equipmentverify
VLOValero Energy CorporationRefining379.831.30verifyverifyRefining marginsverify
MPCMarathon Petroleum CorporationRefining414.650.44verifyverifyRefining marginsverify
PSXPhillips 66Refining / Midstream265.981.17verifyverifyRefining plus midstreamverify
LNGCheniere Energy, Inc.LNG Export308.75-0.24verifyverifyGlobal LNG demandverify
KGSKodiak Gas Services, Inc.Gas Compression45.161.71verifyverifyJumped on a record quarterverify
ETFsXLE (64.96), XOP, OIH, VDE

What type of market are we in: Choppy, Tech remains weak

Key things for this week: This week is all about Nvidia on Tuesday evening, and it’s an unusual setup. It’s the company’s first report since Jensen Huang resigned as CEO on 12 November, with CFO Colette Kress now interim CEO. The stock had already fallen 29.4% in five weeks with no new results, and its P/E is the lowest since 2019. Nvidia guided to revenue of $108.0bn (plus or minus 2%), almost double the same quarter a year earlier. At the 12 November close it was worth about $4.01 trillion, more than the other 83 companies reporting that week combined, so its numbers and guidance will set the tone for the whole AI and semis complex. Around it, the week is a holiday-shopping test: Home Depot and Disney report Tuesday morning, Target, Lowe’s and TJX on Wednesday morning, and Walmart on Thursday morning. Tariff refunds are a common theme across the retailers. On the macro side, October retail sales land on Tuesday morning and the Fed’s October meeting minutes on Wednesday afternoon. UK CPI is also due this week.

Are breakouts working: No

Are breakouts likely to work for the next 3 – 5 days: No

Are breakdowns likely to work for the next 3 – 5 days: No

Should I be trading: Quick 5m ROE’s

Todays watchlist (stocks setting up): Nothing at the moment

SA 13/11/2026 – Money leaving the market – Very high selling pressure

Overall market trend: Bearish phase – day 45

Yesterdays market: Money leaving the market – Very high selling pressure

TC2000 McClellan: -4

Stocks above 40PMA T2108: 47

VIX: 19

52 week highs (US common stocks): 274

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX No trend

$QQQ: No trend

$SPY: No trend

$RSP: Uptrend

$DIA: No trend

$IWM: No trend

$BTC: Downtrend

$SQQQ: No trend

$UVIX: Downtrend

$TLT: Downtrend

$USO: Downtrend

$TNX: No trend

$GLD: Downtrend

$SLV: No trend

$SLX: No trend

2%+ sectors yesterday:

  • None

2%- sectors yesterday:

  • $JETS -3.81%
  • $TAN -3.69%
  • $IBB -2.16%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLE $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $JETS
  • Lagging – $IGV $SMH

Bitcoin: 69k ish

Current market themes:

Theme 1: Blue Wave Clean Energy and Solar Rebound

Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.

Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos

Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
FSLRFirst Solar, Inc.Tech / Solar modules$18.75B-22% (Sep)US manufacturing and 45X credits; $500M buybackBuy (est.); Mizuho PT $328
NXTNextpower Inc.Tech / Solar trackers$11.99Bn/aUtility-scale demand; largest TAN weightBuy (est.)
ENPHEnphase Energy, Inc.Tech / Microinverters$4.26B+13% (Sep)Blue-wave policy relief; residential recoveryHold (est.)
SEDGSolarEdge Technologies, Inc.Tech / Inverters$1.99B+19% (Sep)Up as much as 12% after the electionHold (est.)
RUNSunrun Inc.Industrials / Residential solar$1.82Bn/aResidential credit outlookHold/Buy (est.)
SHLSShoals Technologies Group, Inc.Tech / eBOS$1.26Bn/aUtility-scale buildoutHold (est.)
ARRYArray Technologies, Inc.Tech / Solar trackers$513Mn/aTracker orderbookHold (est.)
CSIQCanadian Solar Inc.Tech / Modules and storage$663Mn/aUp 7%+ after the electionHold (est.)
TET1 Energy Inc.Tech / US module manufacturingn/an/aUp 11% after the electionBuy (est.)
NEENextEra Energy, Inc.Utilities / Renewablesn/an/aNamed among election winners; benefits from lower yieldsBuy (est.)
CWENClearway Energy, Inc.Utilities / Renewable yieldcon/an/aContracted renewables; benefits from lower ratesBuy (est.)
HASIHA Sustainable Infrastructure CapitalFinancials / Climate financen/an/aClean-energy financing pipelineBuy (est.)
BEPBrookfield Renewable PartnersUtilities / Renewablesn/an/aGlobal renewables rallyBuy (est.)
FLNCFluence Energy, Inc.Industrials / Battery storagen/an/aStorage incentivesHold (est.)
AESThe AES CorporationUtilities / Renewables developern/an/aRenewables pipelineHold (est.)
ETFsTAN, ICLN, PBW, QCLN

Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)

Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.

Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres

Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
HCAHCA Healthcare, Inc.Healthcare / Hospitals$101.6B~+6% (pre-election)Up 8.6% after the election; Medicaid exposureBuy (est.)
THCTenet Healthcare CorporationHealthcare / Hospitals$21.6B~+41% (pre-election)ACA subsidy extensionBuy (est.)
UHSUniversal Health Services, Inc.Healthcare / Hospitals and behavioural$11.0B~-13% (pre-election)Laggard catch-up; state-directed paymentsBuy (est.)
ARDTArdent Health, Inc.Healthcare / Hospitals$1.73Bn/aHospital reratingBuy (est.)
ACHCAcadia Healthcare CompanyHealthcare / Behavioural health$2.93Bn/aMedicaid-heavy revenue mixHold (est.)
SGRYSurgery Partners, Inc.Healthcare / Surgical centres$2.04Bn/aVolume recoveryBuy (est.)
CNCCentene CorporationHealthcare / Medicaid MCO$34.7B+66% (30 Oct)Largest Medicaid and ACA insurerHold (est.)
MOHMolina Healthcare, Inc.Healthcare / Medicaid MCO$10.9Bn/aMost exposed to swing-state Medicaid membersHold (est.)
ELVElevance Health, Inc.Healthcare / Managed care$95.1B~+21%Medicaid margins past the troughBuy (est.)
OSCROscar Health, Inc.Healthcare / ACA insurer$9.56Bn/aMost direct ACA-subsidy playHold (est.)
UNHUnitedHealth GroupHealthcare / Managed care$375.3B~+30%Sector leader; Medicare Advantage ratesBuy (est.)
HUMHumana Inc.Healthcare / Medicare Advantage$50.7Bn/aMedicare Advantage rate tailwindHold (est.)
CVSCVS Health CorporationHealthcare / Insurance and pharmacy$119.6Bn/aAetna margin recoveryBuy (est.)
CIThe Cigna GroupHealthcare / Managed care$81.1Bn/aLower Medicaid exposure (defensive)Buy (est.)
ALHCAlignment Healthcare, Inc.Healthcare / Medicare Advantage$1.67Bn/aMedicare Advantage growthBuy (est.)
ETFsIHF, XLV

What type of market are we in: Choppy, Tech remains weak

Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.

Are breakouts working: No

Are breakouts likely to work for the next 3 – 5 days: No

Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns

Should I be trading: WSS only

Todays watchlist (stocks setting up): Nothing at the moment

SA 12/11/2026 – Money entering the market – High buying pressure

Overall market trend: Bearish phase – day 44

Yesterdays market: Money entering the market – High buying pressure

TC2000 McClellan: 49

Stocks above 40PMA T2108: 51

VIX: 17

52 week highs (US common stocks): 308

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX No trend

$QQQ: No trend

$SPY: No trend

$RSP: Uptrend

$DIA: No trend

$IWM: Uptrend

$BTC: Downtrend

$SQQQ: No trend

$UVIX: Downtrend

$TLT: Downtrend

$USO: Downtrend

$TNX: No trend

$GLD: No trend

$SLV: No trend

$SLX: No trend

2%+ sectors yesterday:

  • $SMH +4.82%
  • $XLK +3.23%
  • $XTL +2.35%

2%- sectors yesterday:

  • None

Main sectors monthly trailing:

  • Leading – $XLV $XHB
  • Lagging – $XLE $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $JETS
  • Lagging – $IGV $SMH

Bitcoin: 74k ish

Current market themes:

Theme 1: Blue Wave Clean Energy and Solar Rebound

Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.

Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos

Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
FSLRFirst Solar, Inc.Tech / Solar modules$18.75B-22% (Sep)US manufacturing and 45X credits; $500M buybackBuy (est.); Mizuho PT $328
NXTNextpower Inc.Tech / Solar trackers$11.99Bn/aUtility-scale demand; largest TAN weightBuy (est.)
ENPHEnphase Energy, Inc.Tech / Microinverters$4.26B+13% (Sep)Blue-wave policy relief; residential recoveryHold (est.)
SEDGSolarEdge Technologies, Inc.Tech / Inverters$1.99B+19% (Sep)Up as much as 12% after the electionHold (est.)
RUNSunrun Inc.Industrials / Residential solar$1.82Bn/aResidential credit outlookHold/Buy (est.)
SHLSShoals Technologies Group, Inc.Tech / eBOS$1.26Bn/aUtility-scale buildoutHold (est.)
ARRYArray Technologies, Inc.Tech / Solar trackers$513Mn/aTracker orderbookHold (est.)
CSIQCanadian Solar Inc.Tech / Modules and storage$663Mn/aUp 7%+ after the electionHold (est.)
TET1 Energy Inc.Tech / US module manufacturingn/an/aUp 11% after the electionBuy (est.)
NEENextEra Energy, Inc.Utilities / Renewablesn/an/aNamed among election winners; benefits from lower yieldsBuy (est.)
CWENClearway Energy, Inc.Utilities / Renewable yieldcon/an/aContracted renewables; benefits from lower ratesBuy (est.)
HASIHA Sustainable Infrastructure CapitalFinancials / Climate financen/an/aClean-energy financing pipelineBuy (est.)
BEPBrookfield Renewable PartnersUtilities / Renewablesn/an/aGlobal renewables rallyBuy (est.)
FLNCFluence Energy, Inc.Industrials / Battery storagen/an/aStorage incentivesHold (est.)
AESThe AES CorporationUtilities / Renewables developern/an/aRenewables pipelineHold (est.)
ETFsTAN, ICLN, PBW, QCLN

Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)

Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.

Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres

Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
HCAHCA Healthcare, Inc.Healthcare / Hospitals$101.6B~+6% (pre-election)Up 8.6% after the election; Medicaid exposureBuy (est.)
THCTenet Healthcare CorporationHealthcare / Hospitals$21.6B~+41% (pre-election)ACA subsidy extensionBuy (est.)
UHSUniversal Health Services, Inc.Healthcare / Hospitals and behavioural$11.0B~-13% (pre-election)Laggard catch-up; state-directed paymentsBuy (est.)
ARDTArdent Health, Inc.Healthcare / Hospitals$1.73Bn/aHospital reratingBuy (est.)
ACHCAcadia Healthcare CompanyHealthcare / Behavioural health$2.93Bn/aMedicaid-heavy revenue mixHold (est.)
SGRYSurgery Partners, Inc.Healthcare / Surgical centres$2.04Bn/aVolume recoveryBuy (est.)
CNCCentene CorporationHealthcare / Medicaid MCO$34.7B+66% (30 Oct)Largest Medicaid and ACA insurerHold (est.)
MOHMolina Healthcare, Inc.Healthcare / Medicaid MCO$10.9Bn/aMost exposed to swing-state Medicaid membersHold (est.)
ELVElevance Health, Inc.Healthcare / Managed care$95.1B~+21%Medicaid margins past the troughBuy (est.)
OSCROscar Health, Inc.Healthcare / ACA insurer$9.56Bn/aMost direct ACA-subsidy playHold (est.)
UNHUnitedHealth GroupHealthcare / Managed care$375.3B~+30%Sector leader; Medicare Advantage ratesBuy (est.)
HUMHumana Inc.Healthcare / Medicare Advantage$50.7Bn/aMedicare Advantage rate tailwindHold (est.)
CVSCVS Health CorporationHealthcare / Insurance and pharmacy$119.6Bn/aAetna margin recoveryBuy (est.)
CIThe Cigna GroupHealthcare / Managed care$81.1Bn/aLower Medicaid exposure (defensive)Buy (est.)
ALHCAlignment Healthcare, Inc.Healthcare / Medicare Advantage$1.67Bn/aMedicare Advantage growthBuy (est.)
ETFsIHF, XLV

What type of market are we in: Choppy, SOXX, QQQ, SPY moved to no trend, today will be day 5 of the move from the lows so expect some kind of pull back before the next move if these are the lows.

Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.

Are breakouts working: Selectively

Are breakouts likely to work for the next 3 – 5 days: No, entering day 5 of the move, stocks tend to move in 3 – 5 day bursts.

Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns

Should I be trading: RR no there after 4 up days, only EPs.

Todays watchlist (stocks setting up): Nothing at the moment

SA 11/11/2026 – Money leaving the market – High selling pressure

Overall market trend: Bearish phase – day 43

Yesterdays market: Money leaving the market – High selling pressure

TC2000 McClellan: 42

Stocks above 40PMA T2108: 50

VIX: 19

52 week highs (US common stocks): 311

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: Downtrend

$RSP: Uptrend

$DIA: No trend

$IWM: Uptrend

$BTC: Downtrend

$SQQQ: Uptrend

$UVIX: No trend

$TLT: No trend

$USO: Downtrend

$TNX: No trend

$GLD: No trend

$SLV: No trend

$SLX: No trend

2%+ sectors yesterday:

  • None

2%- sectors yesterday:

  • $TAN -3.70%
  • $XHB -2.63%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLE $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $JETS
  • Lagging – $HACK $SMH

Bitcoin: 74k ish

Current market themes:

Theme 1: Blue Wave Clean Energy and Solar Rebound

Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.

Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos

Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
FSLRFirst Solar, Inc.Tech / Solar modules$18.75B-22% (Sep)US manufacturing and 45X credits; $500M buybackBuy (est.); Mizuho PT $328
NXTNextpower Inc.Tech / Solar trackers$11.99Bn/aUtility-scale demand; largest TAN weightBuy (est.)
ENPHEnphase Energy, Inc.Tech / Microinverters$4.26B+13% (Sep)Blue-wave policy relief; residential recoveryHold (est.)
SEDGSolarEdge Technologies, Inc.Tech / Inverters$1.99B+19% (Sep)Up as much as 12% after the electionHold (est.)
RUNSunrun Inc.Industrials / Residential solar$1.82Bn/aResidential credit outlookHold/Buy (est.)
SHLSShoals Technologies Group, Inc.Tech / eBOS$1.26Bn/aUtility-scale buildoutHold (est.)
ARRYArray Technologies, Inc.Tech / Solar trackers$513Mn/aTracker orderbookHold (est.)
CSIQCanadian Solar Inc.Tech / Modules and storage$663Mn/aUp 7%+ after the electionHold (est.)
TET1 Energy Inc.Tech / US module manufacturingn/an/aUp 11% after the electionBuy (est.)
NEENextEra Energy, Inc.Utilities / Renewablesn/an/aNamed among election winners; benefits from lower yieldsBuy (est.)
CWENClearway Energy, Inc.Utilities / Renewable yieldcon/an/aContracted renewables; benefits from lower ratesBuy (est.)
HASIHA Sustainable Infrastructure CapitalFinancials / Climate financen/an/aClean-energy financing pipelineBuy (est.)
BEPBrookfield Renewable PartnersUtilities / Renewablesn/an/aGlobal renewables rallyBuy (est.)
FLNCFluence Energy, Inc.Industrials / Battery storagen/an/aStorage incentivesHold (est.)
AESThe AES CorporationUtilities / Renewables developern/an/aRenewables pipelineHold (est.)
ETFsTAN, ICLN, PBW, QCLN

Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)

Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.

Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres

Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
HCAHCA Healthcare, Inc.Healthcare / Hospitals$101.6B~+6% (pre-election)Up 8.6% after the election; Medicaid exposureBuy (est.)
THCTenet Healthcare CorporationHealthcare / Hospitals$21.6B~+41% (pre-election)ACA subsidy extensionBuy (est.)
UHSUniversal Health Services, Inc.Healthcare / Hospitals and behavioural$11.0B~-13% (pre-election)Laggard catch-up; state-directed paymentsBuy (est.)
ARDTArdent Health, Inc.Healthcare / Hospitals$1.73Bn/aHospital reratingBuy (est.)
ACHCAcadia Healthcare CompanyHealthcare / Behavioural health$2.93Bn/aMedicaid-heavy revenue mixHold (est.)
SGRYSurgery Partners, Inc.Healthcare / Surgical centres$2.04Bn/aVolume recoveryBuy (est.)
CNCCentene CorporationHealthcare / Medicaid MCO$34.7B+66% (30 Oct)Largest Medicaid and ACA insurerHold (est.)
MOHMolina Healthcare, Inc.Healthcare / Medicaid MCO$10.9Bn/aMost exposed to swing-state Medicaid membersHold (est.)
ELVElevance Health, Inc.Healthcare / Managed care$95.1B~+21%Medicaid margins past the troughBuy (est.)
OSCROscar Health, Inc.Healthcare / ACA insurer$9.56Bn/aMost direct ACA-subsidy playHold (est.)
UNHUnitedHealth GroupHealthcare / Managed care$375.3B~+30%Sector leader; Medicare Advantage ratesBuy (est.)
HUMHumana Inc.Healthcare / Medicare Advantage$50.7Bn/aMedicare Advantage rate tailwindHold (est.)
CVSCVS Health CorporationHealthcare / Insurance and pharmacy$119.6Bn/aAetna margin recoveryBuy (est.)
CIThe Cigna GroupHealthcare / Managed care$81.1Bn/aLower Medicaid exposure (defensive)Buy (est.)
ALHCAlignment Healthcare, Inc.Healthcare / Medicare Advantage$1.67Bn/aMedicare Advantage growthBuy (est.)
ETFsIHF, XLV

What type of market are we in: Bearish, SOXX, QQQ, SPY in downtrends

Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.

Are breakouts working: No, 20% bullish also elevated over 100

Are breakouts likely to work for the next 3 – 5 days: No

Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns

Should I be trading: Only short term 5 ROE for my style of trading

Todays watchlist (stocks setting up): $HPE $TRMB weak structure short

SA 09/11/2026 – Money entering the market – Normal buying pressure

Overall market trend: Bearish phase – day 41

Fridays market: Money entering the market – Normal buying pressure

TC2000 McClellan: 4

Stocks above 40PMA T2108: 44

VIX: 26

52 week highs (US common stocks): 233

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: Downtrend

$RSP: Downtrend

$DIA: Downtrend

$IWM: Downtrend

$BTC: Downtrend

$SQQQ: Uptrend

$UVIX: Uptrend

$TLT: Uptrend

$USO: Downtrend

$TNX: Downtrend

$GLD: Uptrend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors Friday:

  • $SMH +3.62%
  • $XTL +3.44%
  • $TAN +3.38%

2%- sectors Friday:

  • None

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLI $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $TLT
  • Lagging – $HACK $SMH

Bitcoin: 74k ish

Current market themes:

Theme 1: Blue Wave Clean Energy and Solar Rebound

Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.

Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos

Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
FSLRFirst Solar, Inc.Tech / Solar modules$18.75B-22% (Sep)US manufacturing and 45X credits; $500M buybackBuy (est.); Mizuho PT $328
NXTNextpower Inc.Tech / Solar trackers$11.99Bn/aUtility-scale demand; largest TAN weightBuy (est.)
ENPHEnphase Energy, Inc.Tech / Microinverters$4.26B+13% (Sep)Blue-wave policy relief; residential recoveryHold (est.)
SEDGSolarEdge Technologies, Inc.Tech / Inverters$1.99B+19% (Sep)Up as much as 12% after the electionHold (est.)
RUNSunrun Inc.Industrials / Residential solar$1.82Bn/aResidential credit outlookHold/Buy (est.)
SHLSShoals Technologies Group, Inc.Tech / eBOS$1.26Bn/aUtility-scale buildoutHold (est.)
ARRYArray Technologies, Inc.Tech / Solar trackers$513Mn/aTracker orderbookHold (est.)
CSIQCanadian Solar Inc.Tech / Modules and storage$663Mn/aUp 7%+ after the electionHold (est.)
TET1 Energy Inc.Tech / US module manufacturingn/an/aUp 11% after the electionBuy (est.)
NEENextEra Energy, Inc.Utilities / Renewablesn/an/aNamed among election winners; benefits from lower yieldsBuy (est.)
CWENClearway Energy, Inc.Utilities / Renewable yieldcon/an/aContracted renewables; benefits from lower ratesBuy (est.)
HASIHA Sustainable Infrastructure CapitalFinancials / Climate financen/an/aClean-energy financing pipelineBuy (est.)
BEPBrookfield Renewable PartnersUtilities / Renewablesn/an/aGlobal renewables rallyBuy (est.)
FLNCFluence Energy, Inc.Industrials / Battery storagen/an/aStorage incentivesHold (est.)
AESThe AES CorporationUtilities / Renewables developern/an/aRenewables pipelineHold (est.)
ETFsTAN, ICLN, PBW, QCLN

Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)

Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.

Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres

Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
HCAHCA Healthcare, Inc.Healthcare / Hospitals$101.6B~+6% (pre-election)Up 8.6% after the election; Medicaid exposureBuy (est.)
THCTenet Healthcare CorporationHealthcare / Hospitals$21.6B~+41% (pre-election)ACA subsidy extensionBuy (est.)
UHSUniversal Health Services, Inc.Healthcare / Hospitals and behavioural$11.0B~-13% (pre-election)Laggard catch-up; state-directed paymentsBuy (est.)
ARDTArdent Health, Inc.Healthcare / Hospitals$1.73Bn/aHospital reratingBuy (est.)
ACHCAcadia Healthcare CompanyHealthcare / Behavioural health$2.93Bn/aMedicaid-heavy revenue mixHold (est.)
SGRYSurgery Partners, Inc.Healthcare / Surgical centres$2.04Bn/aVolume recoveryBuy (est.)
CNCCentene CorporationHealthcare / Medicaid MCO$34.7B+66% (30 Oct)Largest Medicaid and ACA insurerHold (est.)
MOHMolina Healthcare, Inc.Healthcare / Medicaid MCO$10.9Bn/aMost exposed to swing-state Medicaid membersHold (est.)
ELVElevance Health, Inc.Healthcare / Managed care$95.1B~+21%Medicaid margins past the troughBuy (est.)
OSCROscar Health, Inc.Healthcare / ACA insurer$9.56Bn/aMost direct ACA-subsidy playHold (est.)
UNHUnitedHealth GroupHealthcare / Managed care$375.3B~+30%Sector leader; Medicare Advantage ratesBuy (est.)
HUMHumana Inc.Healthcare / Medicare Advantage$50.7Bn/aMedicare Advantage rate tailwindHold (est.)
CVSCVS Health CorporationHealthcare / Insurance and pharmacy$119.6Bn/aAetna margin recoveryBuy (est.)
CIThe Cigna GroupHealthcare / Managed care$81.1Bn/aLower Medicaid exposure (defensive)Buy (est.)
ALHCAlignment Healthcare, Inc.Healthcare / Medicare Advantage$1.67Bn/aMedicare Advantage growthBuy (est.)
ETFsIHF, XLV

What type of market are we in: Bearish, all indices in downtrends. Markets need to reset and charts setup.

Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.

Are breakouts working: No

Are breakouts likely to work for the next 3 – 5 days: No, all indexes in downtrnds.

Are breakdowns likely to work for the next 3 – 5 days: RR typically not there after big flush 20% bearish study over 100

Should I be trading: Only short term bounce trades using 5m ROE

Todays watchlist (stocks setting up): None at the moment

$SQQQ long 05/11/2026

Entry price – 42.4

SL – 42

Risk – 40 cents (just below LOD)

Target – 1%, 2% & leave runner on

Time of entry – 12:18 GMT

21 ADR – 1.66

Catalyst / setup – Tech weak after elections in pre market, looked for low risk move using5m ROE.

Result – Scaled 50% at 13:01 @ 42.69 , scaled another 50% at 14:30 @ 43.10, runner still running

SA 06/11/2026 – Money leaving the market – Extreme selling pressure

Overall market trend: Bearish phase – day 40

Yesterdays market: Money leaving the market – Extreme selling pressure

TC2000 McClellan: 9

Stocks above 40PMA T2108: 45

VIX: 28

52 week highs (US common stocks): 240

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: No trend

$RSP: No trend

$DIA: No trend

$IWM: No trend

$BTC: Downtrend

$SQQQ: Uptrend

$UVIX: No trend

$TLT: Uptrend

$USO: Downtrend

$TNX: Downtrend

$GLD: No trend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors yesterday:

  • None

2%- sectors yesterday:

  • $SMH -11.21%
  • $XLK -8.00%
  • $XTL -7.84%
  • $HACK -6.88%
  • $IBB -5.04%
  • $IGV -4.39%
  • $XLI -4.12%
  • $XLY -3.83%
  • $JETS -3.73%
  • $TAN -3.71%
  • $IYT -3.54%
  • $XHB -3.41%
  • $XLE -2.98%
  • $XLB -2.91%
  • $XLF -2.87%
  • $XLV -2.50%
  • $KRE -2.46%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLI $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $TLT
  • Lagging – $HACK $SMH

Bitcoin: 76k ish

Themes:

Cybersecurity

Infrastructure

Cloud Computing

Semiconductors

Software

Clean energy

Crypto

Theme 1: Healthcare Leadership, GLP-1 and Big Biopharma Rotation

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
LLYEli Lilly and CompanyPharma / Obesity-Diabetes~$1.2T~+19%Q3 beat and raise; retatrutide Ph3 vs Ozempic; Foundayo rampBuy; Street PT ~$1,330
REGNRegeneron Pharmaceuticals, Inc.Biotech~$95B~+19% est.Q3 beat; +13% on the weekBuy; PT —
ABBVAbbVie Inc.Pharma / Immunology~$400B—Q3 reported 30 Oct; Skyrizi/RinvoqBuy; PT —
JNJJohnson & JohnsonPharma / Medtech~$500B—Defensive bid; oncology growthBuy; PT —
MRKMerck & Co., Inc.Pharma~$250B—Keytruda subQ transitionHold/Buy; PT —
AMGNAmgen Inc.Biotech / Obesity~$170B—MariTide obesity readouts; Q3 due early NovHold/Buy; PT —
VRTXVertex Pharmaceuticals IncorporatedBiotech~$120B—Non-opioid pain and CF franchiseBuy; PT —
GILDGilead Sciences, Inc.Biotech / HIV~$150B—Lenacapavir PrEP launchBuy; PT —
ALNYAlnylam Pharmaceuticals, Inc.Biotech / RNAi~$60B—Amvuttra ATTR-CM growth; joining Nasdaq 100Buy; PT —
ISRGIntuitive Surgical, Inc.Medtech / Robotics~$190B—da Vinci 5 placementsBuy; PT —
BSXBoston Scientific CorporationMedtech~$150B—Farapulse electrophysiology growthBuy; PT —
TMOThermo Fisher Scientific Inc.Life-Science Tools~$200B—Recovery in pharma spendingBuy; PT —
HCAHCA Healthcare, Inc.Hospitals~$100B—Volume and policy tailwindsBuy; PT —
MCKMcKesson CorporationDrug Distribution~$90B—GLP-1 volumes flowing through distributionBuy; PT —
CDNACareDx, Inc.Diagnostics / Transplant~$5B—Top gainer last week: +22.22% to 87.41Buy; PT —
ETFsXLV · XBI · IBB · VHT · XPH

Theme 2: Hormuz Oil Shock and Refining Super-Margins

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
XOMExxon Mobil CorporationIntegrated Oil~$730B~+49%Q3 beat; $20B 2027 buybackBuy; PT ~$173–175
CVXChevron CorporationIntegrated Oil~$330B—Q3 adjusted EPS $5.28; record refinery throughputBuy; PT —
COPConocoPhillipsE&P~$140B—Q3 due early Nov; leveraged to $100 oilBuy; PT —
EOGEOG Resources, Inc.E&P~$75B—Q3 due early NovBuy/Hold; PT —
OXYOccidental Petroleum CorporationE&P~$55B—Permian volumes; high beta to oilHold; PT —
FANGDiamondback Energy, Inc.E&P (Permian)~$50B—Capital returns at $100 oilBuy; PT —
DVNDevon Energy CorporationE&P~$25B—Q3 due early NovBuy/Hold; PT —
MPCMarathon Petroleum CorporationRefining~$65B—Crack spreads at extremesBuy; PT —
VLOValero Energy CorporationRefining~$55B—Diesel marginsBuy; PT —
PSXPhillips 66Refining / Midstream~$60B—Refining plus chemicalsBuy; PT —
PBFPBF Energy Inc.Refining (high beta)~$5B—Most leveraged to crack spreadsHold; PT —
LNGCheniere Energy, Inc.LNG Export~$55B—Qatar LNG disruptionBuy; PT —
SLBSLB LimitedOilfield Services~$60B—Non-Gulf supply build-outBuy; PT —
HALHalliburton CompanyOilfield Services~$25B—North American activityBuy; PT —
MEOHMethanex CorporationChemicals / Methanol~$5B—+14.04% to 71.57 on the weekBuy; PT —
ETFsXLE · XOP · OIH · CRAK · USO

What type of market are we in: Bearish, big sell off yesterday weakness has spread from the Tech & AI trade to the rest of the market. A +1200 selling day on 4% bearish study, which will likely lead to a bear market rally in the coming days.

Key things for this week: Nov 3: US midterm elections, with a possible shift in Congressional control; Nov 6: October nonfarm payrolls and unemployment rate; and AMD reports on 3 Nov. A tech bounce after AMD would be the main threat to the healthcare rotation.

Are breakouts working: No

Are breakouts likely to work for the next 3 – 5 days: No, market would favour quicker trades if we get a bear market rally,

Are breakdowns likely to work for the next 3 – 5 days: No, also too risky at these levels after such a big flush down.

Should I be trading: Only short term bounce trades using 5m ROE

Todays watchlist (stocks setting up): None at the moment

SA 05/11/2026 – Money entering the market – Normal buying pressure

Overall market trend: Bearish phase – day 39

Yesterdays market: Money entering the market – Very high buying pressure

TC2000 McClellan: 85

Stocks above 40PMA T2108: 52

VIX: 17

52 week highs (US common stocks): 329

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: No trend

$RSP: Uptrend

$DIA: No trend

$IWM: Uptrend

$BTC: No trend

$SQQQ: Uptrend

$UVIX: No trend

$TLT: No trend

$USO: Downtrend

$TNX: Downtrend

$GLD: No trend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors yesterday:

  • $JETS +6.70%
  • $TAN +5.65%
  • $XHB +2.43%
  • $XLY +4.26%
  • $RTH +4.21%
  • $XLF +3.51%
  • $XLP +3.36%
  • $XLV +3.06%
  • $IBB +2.63%
  • $IYT +2.83%
  • $IBB +2.63%
  • $XLB +2.49%

2%- sectors yesterday:

  • $XLE -4.74%
  • $SMH -2.75%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLI $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $IYT
  • Lagging – $IGV $SMH

Bitcoin: 80k ish

Themes:

Cybersecurity

Infrastructure

Cloud Computing

Semiconductors

Software

Clean energy

Crypto

Theme 1: Healthcare Leadership, GLP-1 and Big Biopharma Rotation

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
LLYEli Lilly and CompanyPharma / Obesity-Diabetes~$1.2T~+19%Q3 beat and raise; retatrutide Ph3 vs Ozempic; Foundayo rampBuy; Street PT ~$1,330
REGNRegeneron Pharmaceuticals, Inc.Biotech~$95B~+19% est.Q3 beat; +13% on the weekBuy; PT —
ABBVAbbVie Inc.Pharma / Immunology~$400B—Q3 reported 30 Oct; Skyrizi/RinvoqBuy; PT —
JNJJohnson & JohnsonPharma / Medtech~$500B—Defensive bid; oncology growthBuy; PT —
MRKMerck & Co., Inc.Pharma~$250B—Keytruda subQ transitionHold/Buy; PT —
AMGNAmgen Inc.Biotech / Obesity~$170B—MariTide obesity readouts; Q3 due early NovHold/Buy; PT —
VRTXVertex Pharmaceuticals IncorporatedBiotech~$120B—Non-opioid pain and CF franchiseBuy; PT —
GILDGilead Sciences, Inc.Biotech / HIV~$150B—Lenacapavir PrEP launchBuy; PT —
ALNYAlnylam Pharmaceuticals, Inc.Biotech / RNAi~$60B—Amvuttra ATTR-CM growth; joining Nasdaq 100Buy; PT —
ISRGIntuitive Surgical, Inc.Medtech / Robotics~$190B—da Vinci 5 placementsBuy; PT —
BSXBoston Scientific CorporationMedtech~$150B—Farapulse electrophysiology growthBuy; PT —
TMOThermo Fisher Scientific Inc.Life-Science Tools~$200B—Recovery in pharma spendingBuy; PT —
HCAHCA Healthcare, Inc.Hospitals~$100B—Volume and policy tailwindsBuy; PT —
MCKMcKesson CorporationDrug Distribution~$90B—GLP-1 volumes flowing through distributionBuy; PT —
CDNACareDx, Inc.Diagnostics / Transplant~$5B—Top gainer last week: +22.22% to 87.41Buy; PT —
ETFsXLV · XBI · IBB · VHT · XPH

Theme 2: Hormuz Oil Shock and Refining Super-Margins

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
XOMExxon Mobil CorporationIntegrated Oil~$730B~+49%Q3 beat; $20B 2027 buybackBuy; PT ~$173–175
CVXChevron CorporationIntegrated Oil~$330B—Q3 adjusted EPS $5.28; record refinery throughputBuy; PT —
COPConocoPhillipsE&P~$140B—Q3 due early Nov; leveraged to $100 oilBuy; PT —
EOGEOG Resources, Inc.E&P~$75B—Q3 due early NovBuy/Hold; PT —
OXYOccidental Petroleum CorporationE&P~$55B—Permian volumes; high beta to oilHold; PT —
FANGDiamondback Energy, Inc.E&P (Permian)~$50B—Capital returns at $100 oilBuy; PT —
DVNDevon Energy CorporationE&P~$25B—Q3 due early NovBuy/Hold; PT —
MPCMarathon Petroleum CorporationRefining~$65B—Crack spreads at extremesBuy; PT —
VLOValero Energy CorporationRefining~$55B—Diesel marginsBuy; PT —
PSXPhillips 66Refining / Midstream~$60B—Refining plus chemicalsBuy; PT —
PBFPBF Energy Inc.Refining (high beta)~$5B—Most leveraged to crack spreadsHold; PT —
LNGCheniere Energy, Inc.LNG Export~$55B—Qatar LNG disruptionBuy; PT —
SLBSLB LimitedOilfield Services~$60B—Non-Gulf supply build-outBuy; PT —
HALHalliburton CompanyOilfield Services~$25B—North American activityBuy; PT —
MEOHMethanex CorporationChemicals / Methanol~$5B—+14.04% to 71.57 on the weekBuy; PT —
ETFsXLE · XOP · OIH · CRAK · USO

What type of market are we in: Choppy, a big breadth thrust yesterday after elections, 900+ 4% bullish & 329 52 week highs, some big moves in MAG7 yesterday although they gave some back. $SMH used to lead the market now is lagging, either needs to come back in to strength all we need new leaders.

Key things for this week: Nov 3: US midterm elections, with a possible shift in Congressional control; Nov 6: October nonfarm payrolls and unemployment rate; and AMD reports on 3 Nov. A tech bounce after AMD would be the main threat to the healthcare rotation.

Are breakouts working: Selectively.

Are breakouts likely to work for the next 3 – 5 days: Maybe after this big breadth thrust.

Are breakdowns likely to work for the next 3 – 5 days: No

Should I be trading: Look for EP9’s if this is the start of a new bull move. And SIPs

Todays watchlist (stocks setting up): None at the moment

SA 04/11/2026 – Money entering the market – Normal buying pressure

Overall market trend: Bearish phase – day 38

Yesterdays market: Money entering the market – Normal buying pressure

TC2000 McClellan: 48

Stocks above 40PMA T2108: 47

VIX: 21

52 week highs (US common stocks): 229

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: Downtrend

$RSP: Uptrend

$DIA: No trend

$IWM: Uptrend

$BTC: Downtrend

$SQQQ: Uptrend

$UVIX: Uptrend

$TLT: No trend

$USO: Downtrend

$TNX: Downtrend

$GLD: Downtrend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors yesterday:

  • $TAN +3.02%
  • $SMH +2.01%

2%- sectors yesterday:

  • $XHB -2.49%
  • $XLP -2.07%
  • $XLB -2.01%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLI $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $TLT
  • Lagging – $IGV $SMH

Bitcoin: 78k ish

Themes:

Cybersecurity

Infrastructure

Cloud Computing

Semiconductors

Software

Clean energy

Crypto

Theme 1: Healthcare Leadership, GLP-1 and Big Biopharma Rotation

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
LLYEli Lilly and CompanyPharma / Obesity-Diabetes~$1.2T~+19%Q3 beat and raise; retatrutide Ph3 vs Ozempic; Foundayo rampBuy; Street PT ~$1,330
REGNRegeneron Pharmaceuticals, Inc.Biotech~$95B~+19% est.Q3 beat; +13% on the weekBuy; PT —
ABBVAbbVie Inc.Pharma / Immunology~$400B—Q3 reported 30 Oct; Skyrizi/RinvoqBuy; PT —
JNJJohnson & JohnsonPharma / Medtech~$500B—Defensive bid; oncology growthBuy; PT —
MRKMerck & Co., Inc.Pharma~$250B—Keytruda subQ transitionHold/Buy; PT —
AMGNAmgen Inc.Biotech / Obesity~$170B—MariTide obesity readouts; Q3 due early NovHold/Buy; PT —
VRTXVertex Pharmaceuticals IncorporatedBiotech~$120B—Non-opioid pain and CF franchiseBuy; PT —
GILDGilead Sciences, Inc.Biotech / HIV~$150B—Lenacapavir PrEP launchBuy; PT —
ALNYAlnylam Pharmaceuticals, Inc.Biotech / RNAi~$60B—Amvuttra ATTR-CM growth; joining Nasdaq 100Buy; PT —
ISRGIntuitive Surgical, Inc.Medtech / Robotics~$190B—da Vinci 5 placementsBuy; PT —
BSXBoston Scientific CorporationMedtech~$150B—Farapulse electrophysiology growthBuy; PT —
TMOThermo Fisher Scientific Inc.Life-Science Tools~$200B—Recovery in pharma spendingBuy; PT —
HCAHCA Healthcare, Inc.Hospitals~$100B—Volume and policy tailwindsBuy; PT —
MCKMcKesson CorporationDrug Distribution~$90B—GLP-1 volumes flowing through distributionBuy; PT —
CDNACareDx, Inc.Diagnostics / Transplant~$5B—Top gainer last week: +22.22% to 87.41Buy; PT —
ETFsXLV · XBI · IBB · VHT · XPH

Theme 2: Hormuz Oil Shock and Refining Super-Margins

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
XOMExxon Mobil CorporationIntegrated Oil~$730B~+49%Q3 beat; $20B 2027 buybackBuy; PT ~$173–175
CVXChevron CorporationIntegrated Oil~$330B—Q3 adjusted EPS $5.28; record refinery throughputBuy; PT —
COPConocoPhillipsE&P~$140B—Q3 due early Nov; leveraged to $100 oilBuy; PT —
EOGEOG Resources, Inc.E&P~$75B—Q3 due early NovBuy/Hold; PT —
OXYOccidental Petroleum CorporationE&P~$55B—Permian volumes; high beta to oilHold; PT —
FANGDiamondback Energy, Inc.E&P (Permian)~$50B—Capital returns at $100 oilBuy; PT —
DVNDevon Energy CorporationE&P~$25B—Q3 due early NovBuy/Hold; PT —
MPCMarathon Petroleum CorporationRefining~$65B—Crack spreads at extremesBuy; PT —
VLOValero Energy CorporationRefining~$55B—Diesel marginsBuy; PT —
PSXPhillips 66Refining / Midstream~$60B—Refining plus chemicalsBuy; PT —
PBFPBF Energy Inc.Refining (high beta)~$5B—Most leveraged to crack spreadsHold; PT —
LNGCheniere Energy, Inc.LNG Export~$55B—Qatar LNG disruptionBuy; PT —
SLBSLB LimitedOilfield Services~$60B—Non-Gulf supply build-outBuy; PT —
HALHalliburton CompanyOilfield Services~$25B—North American activityBuy; PT —
MEOHMethanex CorporationChemicals / Methanol~$5B—+14.04% to 71.57 on the weekBuy; PT —
ETFsXLE · XOP · OIH · CRAK · USO

What type of market are we in: Choppy, tech out of favour

Key things for this week: Nov 3: US midterm elections, with a possible shift in Congressional control; Nov 6: October nonfarm payrolls and unemployment rate; and AMD reports on 3 Nov. A tech bounce after AMD would be the main threat to the healthcare rotation.

Are breakouts working: Selectively outside of tech

Are breakouts likely to work for the next 3 – 5 days: No

Are breakdowns likely to work for the next 3 – 5 days: 20% study is 52 down suggesting working selectively, $QQQ is at the 200SMA so could bounce, see if money starts coming in.

Should I be trading: No for my method.

Todays watchlist (stocks setting up): None at the moment

SA 03/11/2026 – Money leaving the market – High selling pressure

Overall market trend: Bearish phase – day 37

Yesterdays market: Money leaving the market – High selling pressure

TC2000 McClellan: 80

Stocks above 40PMA T2108: 49

VIX: 22

52 week highs (US common stocks): 251

Seasonality: 

The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.

The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.

The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.

Indices:

$SOXX Downtrend

$QQQ: Downtrend

$SPY: Downtrend

$RSP: Uptrend

$DIA: No trend

$IWM: Uptrend

$BTC: Downtrend

$SQQQ: Uptrend

$UVIX: Uptrend

$TLT: Uptrend

$USO: No trend

$TNX: Downtrend

$GLD: Downtrend

$SLV: Downtrend

$SLX: Downtrend

2%+ sectors yesterday:

  • None

2%- sectors yesterday:

  • $SMH -6.98%
  • $XLK -4.89%
  • $HACK -3.94%
  • $IGV -3.41%
  • $XTL -3.32%
  • $TAN -2.38%
  • $JETS -2.04%

Main sectors monthly trailing:

  • Leading – $XLV $XLP
  • Lagging – $XLI $XLK

Sub sectors monthly trailing:

  • Leading – $RTH $KRE
  • Lagging – $IGV $SMH

Bitcoin: 77k ish

Themes:

Cybersecurity

Infrastructure

Cloud Computing

Semiconductors

Software

Clean energy

Crypto

Theme 1: Healthcare Leadership, GLP-1 and Big Biopharma Rotation

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
LLYEli Lilly and CompanyPharma / Obesity-Diabetes~$1.2T~+19%Q3 beat and raise; retatrutide Ph3 vs Ozempic; Foundayo rampBuy; Street PT ~$1,330
REGNRegeneron Pharmaceuticals, Inc.Biotech~$95B~+19% est.Q3 beat; +13% on the weekBuy; PT —
ABBVAbbVie Inc.Pharma / Immunology~$400B—Q3 reported 30 Oct; Skyrizi/RinvoqBuy; PT —
JNJJohnson & JohnsonPharma / Medtech~$500B—Defensive bid; oncology growthBuy; PT —
MRKMerck & Co., Inc.Pharma~$250B—Keytruda subQ transitionHold/Buy; PT —
AMGNAmgen Inc.Biotech / Obesity~$170B—MariTide obesity readouts; Q3 due early NovHold/Buy; PT —
VRTXVertex Pharmaceuticals IncorporatedBiotech~$120B—Non-opioid pain and CF franchiseBuy; PT —
GILDGilead Sciences, Inc.Biotech / HIV~$150B—Lenacapavir PrEP launchBuy; PT —
ALNYAlnylam Pharmaceuticals, Inc.Biotech / RNAi~$60B—Amvuttra ATTR-CM growth; joining Nasdaq 100Buy; PT —
ISRGIntuitive Surgical, Inc.Medtech / Robotics~$190B—da Vinci 5 placementsBuy; PT —
BSXBoston Scientific CorporationMedtech~$150B—Farapulse electrophysiology growthBuy; PT —
TMOThermo Fisher Scientific Inc.Life-Science Tools~$200B—Recovery in pharma spendingBuy; PT —
HCAHCA Healthcare, Inc.Hospitals~$100B—Volume and policy tailwindsBuy; PT —
MCKMcKesson CorporationDrug Distribution~$90B—GLP-1 volumes flowing through distributionBuy; PT —
CDNACareDx, Inc.Diagnostics / Transplant~$5B—Top gainer last week: +22.22% to 87.41Buy; PT —
ETFsXLV · XBI · IBB · VHT · XPH

Theme 2: Hormuz Oil Shock and Refining Super-Margins

TickerCompany NameSector/IndustryMarket CapYTD ReturnKey CatalystAnalyst Consensus
XOMExxon Mobil CorporationIntegrated Oil~$730B~+49%Q3 beat; $20B 2027 buybackBuy; PT ~$173–175
CVXChevron CorporationIntegrated Oil~$330B—Q3 adjusted EPS $5.28; record refinery throughputBuy; PT —
COPConocoPhillipsE&P~$140B—Q3 due early Nov; leveraged to $100 oilBuy; PT —
EOGEOG Resources, Inc.E&P~$75B—Q3 due early NovBuy/Hold; PT —
OXYOccidental Petroleum CorporationE&P~$55B—Permian volumes; high beta to oilHold; PT —
FANGDiamondback Energy, Inc.E&P (Permian)~$50B—Capital returns at $100 oilBuy; PT —
DVNDevon Energy CorporationE&P~$25B—Q3 due early NovBuy/Hold; PT —
MPCMarathon Petroleum CorporationRefining~$65B—Crack spreads at extremesBuy; PT —
VLOValero Energy CorporationRefining~$55B—Diesel marginsBuy; PT —
PSXPhillips 66Refining / Midstream~$60B—Refining plus chemicalsBuy; PT —
PBFPBF Energy Inc.Refining (high beta)~$5B—Most leveraged to crack spreadsHold; PT —
LNGCheniere Energy, Inc.LNG Export~$55B—Qatar LNG disruptionBuy; PT —
SLBSLB LimitedOilfield Services~$60B—Non-Gulf supply build-outBuy; PT —
HALHalliburton CompanyOilfield Services~$25B—North American activityBuy; PT —
MEOHMethanex CorporationChemicals / Methanol~$5B—+14.04% to 71.57 on the weekBuy; PT —
ETFsXLE · XOP · OIH · CRAK · USO

What type of market are we in: Selling off, rotation out of tech

Key things for this week: Nov 3: US midterm elections, with a possible shift in Congressional control; Nov 6: October nonfarm payrolls and unemployment rate; and AMD reports on 3 Nov. A tech bounce after AMD would be the main threat to the healthcare rotation.

Are breakouts working: Selectively outside of tech

Are breakouts likely to work for the next 3 – 5 days: No

Are breakdowns likely to work for the next 3 – 5 days: 20% study is 40 down suggesting working selectively, $QQQ is at the 200SMA so could bounce, see if money starts coming in.

Should I be trading: No for my method.

Todays watchlist (stocks setting up): None at the moment